苏州中化药品工业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
100
NMPA:100
Drug Approvals
Telmisartan and Hydrochlorothiazide Tablets
- Product Name
- 替米沙坦氢氯噻嗪片
- Approval Number
- 国药准字H20247022
- Approval Date
- Jan 29, 2024
NMPA
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Sustained-release Tablets
- Product Name
- 西替伪麻缓释片
- Approval Number
- 国药准字H20090113
- Approval Date
- Sep 28, 2023
NMPA
Calcium Polycarbophil Granules
- Product Name
- 聚卡波非钙颗粒
- Approval Number
- 国药准字H20233989
- Approval Date
- Aug 1, 2023
NMPA
Cefalotin Sodium for Injection
- Product Name
- 注射用头孢噻吩钠
- Approval Number
- 国药准字H20073966
- Approval Date
- May 7, 2022
NMPA
Cefalotin Sodium for Injection
- Product Name
- 注射用头孢噻吩钠
- Approval Number
- 国药准字H20073965
- Approval Date
- May 7, 2022
NMPA
Cefalotin Sodium for Injection
- Product Name
- 注射用头孢噻吩钠
- Approval Number
- 国药准字H20073967
- Approval Date
- May 7, 2022
NMPA
Cefepime Hydrochloride for Injection
- Product Name
- 注射用盐酸头孢吡肟
- Approval Number
- 国药准字H20184163
- Approval Date
- Dec 6, 2021
NMPA
Cefepime Hydrochloride for Injection
- Product Name
- 注射用盐酸头孢吡肟
- Approval Number
- 国药准字H20123259
- Approval Date
- Dec 6, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
Clinical Trials
No trials found
News
No news found